Professor Nicholas Buckley’s research focusses on toxicology and adverse effects of drugs, pesticides and snakebite using a range of methods including systematic reviews, clinical trials, drug development, public health interventions, pharmaco-epidemiology and policy analysis, leading to over 300 articles in refereed journals.

Many of Professor Buckley’s research findings have translated into changed practice and improved outcomes, aided by key leadership roles: Chair of the Australian Medicines Handbook Editorial Advisory board, Chair of Toxicology and Toxinology Australian Therapeutic Guidelines panel, Membership of the Advisory Committee on Safety of Medicines (2009-2016) and by being a consultant Clinical Toxicologist to several Poisons Information Centres.

Professor Peter Cistulli is recognised nationally and internationally as a clinical and research leader in the field of Respiratory and Sleep Medicine. He has made major contributions to the understanding of the causes and treatment of common sleep disorders, such as Obstructive Sleep Apnoea (OSA). His pioneering work on novel therapies, and particularly oral appliances for the treatment of OSA, has changed clinical practice in the field and has contributed to the development of a new interdisciplinary field of Dental Sleep Medicine, bridging medicine and dentistry.

Through distinguished contribution to clinical practice, research and teaching, Professor Cistulli has advanced his field.

Professor Guy Marks is a world-leading respiratory physician and epidemiologist, whose outstanding contributions to the fields of asthma, chronic lung disease, tuberculosis (TB) and air pollution have transformed the national and global responses to these health problems. His sustained research through the Woolcock Institute of Medical Research has been recognised by major awards from the NHMRC, the Thoracic Society, the Ingham Institute and UNSW Sydney.

Professor Marks has made important contributions to training and policy development in lung health and TB control in Australia and internationally. His sustained leadership within the International Union Against TB and Lung Diseases led to his appointment as President in 2019.

Professor Jennifer Martin is dual-trained clinical pharmacologist and physician based in Newcastle. Through combining her clinical practice with a strong program of research, she has driven clinical impact through knowledge translation and informing effective government policy and regulation with evidence-based research. Her research spans the full translational pathway, from discovery and animal development work, to Phase I-IV clinical trials, and implementation of research into the therapeutic setting.

Professor Martin is considered a leader in her field and is an expert advisor to the health and pharmaceutical sector, industry and various governments, particularly in the area of drug development and pharmaceutical regulation.

Professor Steve Vucic is a clinical academic and internationally recognised researcher in the field of neuroscience with an emphasis on understanding amyotrophic lateral sclerosis (ALS) pathogenesis. His key discoveries relating to identification of “cortical hyperexcitability” as an important pathophysiological mechanism in ALS have transformed the understanding of ALS, resulted in novel therapeutic approaches and led to development of pharmacodynamic biomarkers. In addition, a much-needed diagnostic investigation was developed for ALS, termed threshold tracking transcranial magnetic stimulation (TMS), enabling earlier diagnosis and thereby recruitment into clinical trials.

Professor Vucic has published and presented extensively and has received national and international accolades for his research.